triamcinolone acetonide has been researched along with MS (Multiple Sclerosis) in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Brenmoehl, J; Fitzner, B; Hecker, M; Hoeflich, A; Tuchscherer, A; Walz, C; Zettl, UK | 1 |
| Jovanović, S; Petrović, N; Radotić, F; Šarenac Vulović, T; Tončić, Z; Živković, M | 1 |
| Abu-Mugheisib, M; Benecke, R; Hoffmann, F; Kamin, F; Koehler, W; Petzold, A; Rommer, PS; Tumani, H; Winkelmann, A; Zettl, UK | 1 |
| Abu-Mugheisib, M; Benecke, R; Hoffmann, F; Kamin, F; Koehler, W; Rommer, PS; Winkelmann, A; Zettl, UK | 1 |
| Hellwig, K; Müller, T; Przuntek, H; Stein, FJ | 1 |
| Brune, N; Hellwig, K; Hoffmann, V; Islamova, S; Kuhn, W; Lukas, C; Müller, T; Pöhlau, D; Przuntek, H; Schimrigk, S | 1 |
| Neu, I; Reusche, E; Rodiek, S | 1 |
| Heun, R; Rüttinger, H; Schimrigk, K; Sliwka, U | 1 |
| Emser, W; Heun, R; Schimrigk, K | 1 |
4 trial(s) available for triamcinolone acetonide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.
Topics: Disability Evaluation; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome; Triamcinolone Acetonide; Urinary Bladder; Walking | 2016 |
Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms.
Topics: Adult; Aged; Delayed-Action Preparations; Drug Administration Schedule; Evoked Potentials, Somatosensory; Glucocorticoids; Humans; Injections, Spinal; Length of Stay; Median Nerve; Middle Aged; Multiple Sclerosis; Reaction Time; Spinal Diseases; Tibial Nerve; Triamcinolone Acetonide; Walking | 2004 |
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients.
Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Disability Evaluation; Disease Progression; Drug Administration Schedule; Female; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis; Phosphopyruvate Hydratase; S100 Proteins; Severity of Illness Index; Treatment Outcome; Triamcinolone Acetonide; Walking | 2006 |
Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study.
Topics: Adrenal Cortex Hormones; Female; Headache; Humans; Injections, Intravenous; Injections, Spinal; Male; Methylprednisolone; Multiple Sclerosis; Severity of Illness Index; Triamcinolone Acetonide | 1992 |
5 other study(ies) available for triamcinolone acetonide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
Topics: Adult; Biomarkers; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor II; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Triamcinolone Acetonide | 2020 |
Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Fundus Oculi; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Tenon Capsule; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Intermediate; Visual Acuity; Young Adult | 2017 |
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients.
Topics: Adult; Anti-Inflammatory Agents; Axons; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis; Neurofilament Proteins; Neuroglia; Prognosis; Prospective Studies; S100 Calcium Binding Protein beta Subunit; tau Proteins; Triamcinolone Acetonide | 2014 |
[Endogenous cortisol levels after intrathecal injection of triamicinolone acetonide in patients with neurological disease (author's transl)].
Topics: Humans; Hydrocortisone; Injections, Intramuscular; Injections, Spinal; Multiple Sclerosis; Nervous System Diseases; Time Factors; Triamcinolone Acetonide | 1978 |
[Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].
Topics: Administration, Oral; Adult; Aged; Disability Evaluation; Electroencephalography; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Infusions, Intravenous; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Triamcinolone Acetonide | 1989 |